Viewing Study NCT00102466


Ignite Creation Date: 2025-12-24 @ 3:59 PM
Ignite Modification Date: 2026-02-03 @ 2:56 PM
Study NCT ID: NCT00102466
Status: COMPLETED
Last Update Posted: 2020-12-17
First Post: 2005-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None vildagliptin View